Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.37 |
| ▸ | FDPS | P14324 | 2/20 | 0.36 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.36 |
| ▸ | GSTO1 | P78417 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | RARB | P10826 | 1/20 | 0.34 |
| ▸ | MAOA | P21397 | 3/20 | 0.34 |
| ▸ | MAOB | P27338 | 3/20 | 0.34 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | GPR88 | Q9GZN0 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12284544 | 0.80 | TDP1 (0.35) | TDP1ALOX5FDPSGGPS1HPGD | |
| SCHEMBL13502294 | 0.80 | TDP1 (0.37) | TDP1ALOX5FDPSGGPS1MAPK1 | |
| SCHEMBL4762110 | 0.77 | KCNA3 (0.52) | TDP1ALOX5FDPSGGPS1MAPK1 | |
| SCHEMBL7536898 | 0.77 | KCNA3 (0.52) | TDP1ALOX5FDPSGGPS1MAPK1 | |
| SCHEMBL18837357 | 0.76 | NPC1 (0.55) | TDP1ALOX5GSTO1MAPK1NPC1 | |
| SCHEMBL96053 | 0.76 | MAPT (0.49) | TDP1ALOX5PDK2NPC1RAB9A | |
| SCHEMBL13502291 | 0.75 | TDP1 (0.41) | TDP1ALOX5PDK2FDPSGGPS1 | |
| SCHEMBL16340342 | 0.75 | TDP1 (0.58) | TDP1ALOX5FDPSGGPS1GSTO1 | |
| SCHEMBL6857008 | 0.75 | TDP1 (0.58) | TDP1ALOX5FDPSGGPS1GSTO1 | |
| SCHEMBL27483201 | 0.74 | LTA4H (0.46) | TDP1ALOX5FDPSGGPS1RARB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7662478-B2 | Polymer and polymer light-emitting device using the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-02-16 | — | — | US | disclosed |
| US-20080103278-A1 | NEW POLYMER AND POLYMER LIGHT-EMITTING DEVICE USING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED | 2008-05-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080103278-A1 | NEW POLYMER AND POLYMER LIGHT-EMITTING DEVICE USING THE SAME | CRY1, ARCN1, CORO1A | TDP1 1847/4885ALOX5 3501/4885PDK2 3752/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.